Aseptic Processing Overview and Validation

12:00 PM ET | 09:00 AM PT | 11:00 AM CT Duration 180 Minutes

Webinar Includes : All the training handouts , certificate ,Q/A and 180 mins Live Webinar

"Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations"

Requirements for aseptic and bulk manufacturing operations

Description

This course will provide an overview of the requirements for aseptic and bulk manufacturing operations, including facility design, contamination controls and acceptable personnel behaviors.

Cleanroom classifications and the techniques for proper cleaning and disinfection are presented; along with a high-level overview of microbiology in regards to cleanroom environmental monitoring and the associated impact to product and patient health and safety.  This course will also review the guidance provided in USP <1116> to ensure compliance with regulatory expectations are met.

Why should you attend 

At the completion of this course, attendees will be able to:

  • Explain the difference between Aseptic and Bulk processing
  • Understand facility and personnel requirements necessary to maintain microbial control
  • Explain basic principles of microbiology and microorganism recovery in relation to cleanroom environmental monitoring (EM) and impact to product
  • Understand the gowning requirements associated with different cleanroom classifications
  • Explain basic principles of aseptic processing, including:
    • Cleanliness classifications
    • Proper Engineering controls
    • Process differences between aseptically produced and terminally sterilized product
    • Relation of manufacturing and handling procedures to sources of product contamination
    • The differences between cleaning, disinfection and sanitization
    • Proper cleaning / disinfectant technique
    • Elements of a robust environmental program and why EM is important
    • The purpose of media fills, and elements critical to their success
    • The role of isolator technology
  • Identify behaviors that are or are not appropriate when working in controlled areas, and why
  • Identify ways that they can impact/improve site-specific EM and aseptic behavior issues

Areas Covered

Topic 1:   Basic Micro Review

• The role of environmental monitoring

• Types & sources of microorganisms

• The impact of microorganisms on product and patient health and safety

Topic 2:  Review Aseptic Processing Basics

• Cleanliness classifications

• Process differences between aseptically produced and terminally sterilized product

• Relation of manufacturing and handling procedures to sources of product contamination

• The differences between and the purposes of cleaning, disinfection and sanitization

• Proper cleaning techniques

• The role of isolator technology

Topic 3:  Review Clean Area Behaviors

• Personnel gowning requirements

• Good clean area behaviors/practices

• Practices to avoid – and why

• Review site-specific EM/aseptic behavior observations/risks & ask attendees to brainstorm ways to                            change/improve/eliminate these behaviors & risks

Topic 4:  Aseptic Validation

• The purpose of media fills, and elements critical to their succes

Who will Benefit

Operations employees who are required to enter controlled environments as part of their job function – includes some or all of the employees in the following departments:

  • Production
  • QC Micro
  • Engineering & Validation
  • Facilities / Maintenance
  • Quality Assurance

Industries who can attend

This 180-minute online course is intended for professionals in the Medical Device, Biotechnology,Pharmaceutical Industry. Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel


Speaker Profile

Kelly Thomas

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations.  Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.  
Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

Back to Top